Oral Wegovy (semaglutide 25mg, approved December 2025) averaged 13.6% weight loss in OASIS 4 — close to the injection's 14.9%. The real difference is the ritual: a daily pill taken fasting with minimal water, and nothing by mouth for 30 minutes after. Same food rules, plus one timing rule that rewrites breakfast.
| A | B | |
|---|---|---|
| Form | Weekly injection | Daily pill |
| Weight loss | 14.9% (STEP 1) | 13.6% (OASIS 4) |
| Dosing | Once a week | Every morning, fasting |
| Food timing | None hard-coded | 30-min fast after pill |
| Breakfast | Flexible | Pushed 30-45 min later |
The same judgment framework runs across this site — protein, fiber and how heavy a food sits on a slow stomach.
| Easy on both | Risky on both |
|---|---|
|
|
Close: 13.6% average weight loss for oral Wegovy vs 14.9% for the injection, and consistent takers did even better. The gap is small; the ritual difference is the bigger factor.
30 minutes after, per the label — with minimal water at dosing time. After the window, a protein-first breakfast fits the standard GLP-1 food framework.
Switching is a provider conversation — doses and schedules differ. The food framework carries over unchanged.
This comparison presents published trial data (STEP, SURMOUNT, SCALE, OASIS 4) and FDA label information for reference. It is not medical advice and does not recommend any medication. Prescription decisions belong to you and your healthcare provider.